Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report

The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor that is used to treat metastatic breast cancer. A side effect of abemac...

Descripción completa

Detalles Bibliográficos
Autores principales: Horie, Tatsuo, Kijima, Tsunetaka, Yamaguchi, Minekazu, Honda, Satoshi, Horie, Miyako, Ishitobi, Kazunari, Yamagata, Shingo, Sakano, Shigeru, Kurokohchi, Kazutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849062/
https://www.ncbi.nlm.nih.gov/pubmed/33604051
http://dx.doi.org/10.3892/mco.2021.2223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849062/
https://www.ncbi.nlm.nih.gov/pubmed/33604051
http://dx.doi.org/10.3892/mco.2021.2223

Ejemplares similares